# Finwise Bancorp: financial statements, quarterly

FINW · Nasdaq · CIK 1856365 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/finw.md) · [Financials](/companies/finw/financials.md) · [Filings](/companies/finw/filings.md) · [Insiders](/companies/finw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/finw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,801](/filings/0001856365-23-000040.md) | [3,685 d](/filings/0001856365-24-000013.md) | [3,639](/filings/0001856365-24-000031.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [1,696](/filings/0001856365-24-000065.md) | [1,655 d](/filings/0001856365-25-000006.md) | [1,194](/filings/0001856365-25-000027.md) | [998](/filings/0001628280-25-039618.md) | [1,157](/filings/0001856365-25-000045.md) | [898 d](/filings/0001856365-26-000006.md) | [1,247](/filings/0001856365-26-000051.md) | [1,330](/filings/0001856365-26-000106.md) | [1,520](/filings/0001856365-25-000045.md) | [1,572 d](/filings/0001856365-26-000006.md) | [1,063](/filings/0001856365-26-000051.md) | [672](/filings/0001856365-26-000106.md) |
| Net income | $k | [4,804](/filings/0001856365-24-000065.md) | [4,157 d](/filings/0001856365-25-000006.md) | [3,315](/filings/0001856365-25-000027.md) | [3,180](/filings/0001628280-25-039618.md) | [3,454](/filings/0001856365-25-000045.md) | [2,793 d](/filings/0001856365-26-000006.md) | [3,189](/filings/0001856365-26-000051.md) | [4,097](/filings/0001856365-26-000106.md) | [4,891](/filings/0001856365-25-000045.md) | [3,915 d](/filings/0001856365-26-000006.md) | [2,735](/filings/0001856365-26-000051.md) | [2,132](/filings/0001856365-26-000106.md) |
| Diluted EPS | $ per share | [0.37](/filings/0001856365-24-000065.md) | not reported | [0.25](/filings/0001856365-25-000027.md) | [0.24](/filings/0001628280-25-039618.md) | [0.25](/filings/0001856365-25-000045.md) | not reported | [0.23](/filings/0001856365-26-000051.md) | [0.29](/filings/0001856365-26-000106.md) | [0.34](/filings/0001856365-25-000045.md) | not reported | [0.20](/filings/0001856365-26-000051.md) | [0.15](/filings/0001856365-26-000106.md) |
| Basic EPS | $ per share | [0.38](/filings/0001856365-24-000065.md) | not reported | [0.26](/filings/0001856365-25-000027.md) | [0.25](/filings/0001628280-25-039618.md) | [0.26](/filings/0001856365-25-000045.md) | not reported | [0.24](/filings/0001856365-26-000051.md) | [0.31](/filings/0001856365-26-000106.md) | [0.36](/filings/0001856365-25-000045.md) | not reported | [0.21](/filings/0001856365-26-000051.md) | [0.16](/filings/0001856365-26-000106.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [127](/filings/0001856365-23-000040.md) | [117](/filings/0001856365-25-000006.md) | [116](/filings/0001856365-24-000031.md) | [89.0](/filings/0001856365-24-000052.md) | [85.8](/filings/0001856365-24-000065.md) | [109](/filings/0001856365-26-000006.md) | [120](/filings/0001856365-25-000027.md) | [90.1](/filings/0001628280-25-039618.md) | [106](/filings/0001856365-25-000045.md) | [163](/filings/0001856365-26-000106.md) | [96.9](/filings/0001856365-26-000051.md) | [93.6](/filings/0001856365-26-000106.md) |
| Total assets | $m | [555](/filings/0001856365-23-000040.md) | [586](/filings/0001856365-25-000006.md) | [611](/filings/0001856365-24-000031.md) | [618](/filings/0001856365-24-000052.md) | [683](/filings/0001856365-24-000065.md) | [746](/filings/0001856365-26-000006.md) | [804](/filings/0001856365-25-000027.md) | [842](/filings/0001628280-25-039618.md) | [900](/filings/0001856365-25-000045.md) | [977](/filings/0001856365-26-000106.md) | [899](/filings/0001856365-26-000051.md) | [925](/filings/0001856365-26-000106.md) |
| Total liabilities | $m | [405](/filings/0001856365-23-000040.md) | [431](/filings/0001856365-25-000006.md) | [448](/filings/0001856365-24-000031.md) | [452](/filings/0001856365-24-000052.md) | [513](/filings/0001856365-24-000065.md) | [572](/filings/0001856365-26-000006.md) | [627](/filings/0001856365-25-000027.md) | [661](/filings/0001628280-25-039618.md) | [712](/filings/0001856365-25-000045.md) | [784](/filings/0001856365-26-000106.md) | [703](/filings/0001856365-26-000051.md) | [726](/filings/0001856365-26-000106.md) |
| Shareholders' equity | $m | [150](/filings/0001856365-24-000065.md) | [155](/filings/0001856365-26-000006.md) | [162](/filings/0001628280-25-039618.md) | [166](/filings/0001856365-25-000045.md) | [170](/filings/0001856365-25-000045.md) | [174](/filings/0001856365-26-000106.md) | [177](/filings/0001856365-26-000106.md) | [182](/filings/0001856365-26-000106.md) | [188](/filings/0001856365-25-000045.md) | [193](/filings/0001856365-26-000106.md) | [197](/filings/0001856365-26-000106.md) | [199](/filings/0001856365-26-000106.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.3 d](/filings/0001856365-24-000065.md) | [9.7 d](/filings/0001856365-25-000006.md) | [1.8](/filings/0001856365-25-000027.md) | [(7.6) d](/filings/0001628280-25-039618.md) | [(9.8) d](/filings/0001856365-25-000045.md) | [0.7 d](/filings/0001856365-26-000006.md) | [(21.6)](/filings/0001856365-26-000051.md) | [(18.3) d](/filings/0001856365-26-000106.md) | [3.5 d](/filings/0001856365-25-000045.md) | [8.1 d](/filings/0001856365-26-000006.md) | [19.7](/filings/0001856365-26-000051.md) | [(25.7) d](/filings/0001856365-26-000106.md) |
| Capital expenditure | $m | [1.7 d](/filings/0001856365-24-000065.md) | [1.1 d](/filings/0001856365-25-000006.md) | [1.2](/filings/0001856365-25-000027.md) | [0.1 d](/filings/0001628280-25-039618.md) | [3.6 d](/filings/0001856365-25-000045.md) | [(3.8) d](/filings/0001856365-26-000006.md) | [0.1](/filings/0001856365-26-000051.md) | [0.1 d](/filings/0001856365-26-000106.md) | [0.0 d](/filings/0001856365-25-000045.md) | [0.0 d](/filings/0001856365-26-000006.md) | [0.0](/filings/0001856365-26-000051.md) | [0.0 d](/filings/0001856365-26-000106.md) |
| Share repurchases | $m | [2.4 d](/filings/0001856365-24-000065.md) | [0.0 d](/filings/0001856365-25-000006.md) | [0.2](/filings/0001856365-25-000027.md) | [0.3 d](/filings/0001628280-25-039618.md) | [(0.0) d](/filings/0001856365-25-000045.md) | [0.0 d](/filings/0001856365-26-000006.md) | [0.0](/filings/0001856365-25-000027.md) | [0.0 d](/filings/0001856365-26-000106.md) | [0.0 d](/filings/0001856365-25-000045.md) | [0.0 d](/filings/0001856365-26-000006.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.3](/filings/0001856365-23-000040.md) | [13.2](/filings/0001856365-24-000031.md) | [13.0](/filings/0001856365-24-000052.md) | [12.9](/filings/0001856365-24-000065.md) | [13.0](/filings/0001856365-25-000027.md) | [13.1](/filings/0001628280-25-039618.md) | [13.3](/filings/0001856365-25-000045.md) | [13.5](/filings/0001856365-26-000051.md) | [13.5](/filings/0001856365-26-000106.md) | [13.6](/filings/0001856365-25-000045.md) | [13.6](/filings/0001856365-26-000051.md) | [13.7](/filings/0001856365-26-000106.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,882,680 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001856365-26-000106.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.